SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-033250
Filing Date
2020-03-13
Accepted
2020-03-13 17:22:21
Documents
3
Period of Report
2020-03-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2012749-1_8k.htm 8-K 19916
2 EXHIBIT 99.1 tm2012749d1_ex99-1.htm EX-99.1 84427
3 GRAPHIC tm2012749d1_ex99-1img001.jpg GRAPHIC 3718
  Complete submission text file 0001104659-20-033250.txt   110752
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35619 | Film No.: 20714005
SIC: 2834 Pharmaceutical Preparations